Hap Trading, LLC Fibrogen Inc Transaction History

Hap Trading, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$9.93 - $15.39 $195,293 - $302,675	-19,667 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$10.18 - $26.64 $88,688 - $232,087	8,712 Added 79.53%	19,667 $201,000
Q2 2021 Aug 11, 2021	SELL	$18.57 - $35.68 $124,159 - $238,556	-6,686 Reduced 37.9%	10,955 $292,000
Q3 2019 Nov 12, 2019	BUY	$36.98 - $48.45 $652,364 - $854,706	17,641 New	17,641 $652,000
Q4 2018 Feb 12, 2019	SELL	$37.97 - $60.16 $2.2 Million - $3.49 Million	-58,018 Closed	0 $0
Q3 2018 Nov 09, 2018	SELL	$56.3 - $67.25 $320,234 - $382,518	-5,688 Reduced 8.93%	58,018 $3.53 Million
Q2 2018 Aug 13, 2018	BUY	$44.9 - $64.95 $2.86 Million - $4.14 Million	63,706 New	63,706 $3.99 Million

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.